Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannelore V Heemers

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Current Drug Targets|April 10, 2013
Androgen receptor and prostate cancer: new insights in an old target translate into novel therapeutic strategiesHannelore V Heemers
International Journal of Biological Sciences|June 21, 2014
Targeting androgen receptor action for prostate cancer treatment: does the post-receptor level provide novel opportunities?Hannelore V Heemers
Current Drug Targets|March 9, 2013
Identification of a RhoA- and SRF-dependent mechanism of androgen action that is associated with prostate cancer progressionHannelore V Heemers
European Urology|February 20, 2021
Treatment-induced Treatment Sensitization in Metastatic Castration-resistant Prostate CancerShilpa Gupta, Hannelore V Heemers
Oncogene|April 24, 2024
Alternative splicing in prostate cancer progression and therapeutic resistanceChitra Rawat, Hannelore V Heemers
Endocrine-Related Cancer|June 6, 2023
Deregulated kinase action in prostate cancer: molecular basis and therapeutic implicationsNidhi Singh, Hannelore V Heemers
Endocrinology|May 5, 2026
Breaking the bonds: targeting protein dimerization for prostate cancer therapyNidhi Singh, Hannelore V Heemers
Methods in Molecular Biology (Clifton, N.J.)|May 23, 2018
Functional Studies on Steroid ReceptorsSimon Schlanger, Hannelore V Heemers
Discovery Medicine|June 3, 2014
Alternative approaches to prevent androgen action in prostate cancer: are we there yet?May Elbanna, Hannelore V Heemers
Cancers|August 27, 2021
Somatic Alterations Impact AR Transcriptional Activity and Efficacy of AR-Targeting Therapies in Prostate CancerGaurav Chauhan, Hannelore V Heemers
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Current Drug Targets|April 10, 2013
Androgen receptor and prostate cancer: new insights in an old target translate into novel therapeutic strategiesHannelore V Heemers
International Journal of Biological Sciences|June 21, 2014
Targeting androgen receptor action for prostate cancer treatment: does the post-receptor level provide novel opportunities?Hannelore V Heemers
Current Drug Targets|March 9, 2013
Identification of a RhoA- and SRF-dependent mechanism of androgen action that is associated with prostate cancer progressionHannelore V Heemers
European Urology|February 20, 2021
Treatment-induced Treatment Sensitization in Metastatic Castration-resistant Prostate CancerShilpa Gupta, Hannelore V Heemers
Oncogene|April 24, 2024
Alternative splicing in prostate cancer progression and therapeutic resistanceChitra Rawat, Hannelore V Heemers
Endocrine-Related Cancer|June 6, 2023
Deregulated kinase action in prostate cancer: molecular basis and therapeutic implicationsNidhi Singh, Hannelore V Heemers
Endocrinology|May 5, 2026
Breaking the bonds: targeting protein dimerization for prostate cancer therapyNidhi Singh, Hannelore V Heemers
Methods in Molecular Biology (Clifton, N.J.)|May 23, 2018
Functional Studies on Steroid ReceptorsSimon Schlanger, Hannelore V Heemers
Discovery Medicine|June 3, 2014
Alternative approaches to prevent androgen action in prostate cancer: are we there yet?May Elbanna, Hannelore V Heemers
Cancers|August 27, 2021
Somatic Alterations Impact AR Transcriptional Activity and Efficacy of AR-Targeting Therapies in Prostate CancerGaurav Chauhan, Hannelore V Heemers
Pageof 5